Journal
JOURNAL OF PROTEOMICS
Volume 165, Issue -, Pages 113-118Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jprot.2017.06.016
Keywords
Amyloidosis; Decellularisation; Proteomics; Amyloid typing
Categories
Funding
- University College London Amyloidosis Research Fund
- U.K. Medical Research Council [MR/K000187/1]
- Cariplo Foundation [2013-0964, 2014-0700]
- Telethon Foundation [GG14127]
- Italian Ministry of Health [RF-2013-02355259]
- Royal Free Charity
- Medical Research Council [G7900510, MR/K000187/1] Funding Source: researchfish
- MRC [MR/K000187/1, G7900510] Funding Source: UKRI
Ask authors/readers for more resources
Diagnosis and treatment of systemic amyloidosis depend on accurate identification of the specific amyloid fibril protein forming the tissue deposits. Confirmation of monoclonal immunoglobulin light chain amyloidosis (AL), requiring cytotoxic chemotherapy, and avoidance of such treatment in non-AL amyloidosis, are particularly important. Proteomic analysis characterises amyloid proteins directly. It complements immunohistochemical staining of amyloid to identify fibril proteins and gene sequencing to identify mutations in the fibril precursors. However, proteomics sometimes detects more than one potentially amyloidogenic protein, especially immunoglobulins and transthyretin which are abundant plasma proteins. Ambiguous results are most challenging in the elderly as both AL and transthyretin (ATTR) amyloidosis are usually present in this group. We have lately described a procedure for tissue decellularisation which retains the structure, integrity and composition of amyloid but removes proteins that are not integrated within the deposits. Here we show that use of this procedure before proteomic analysis eliminates ambiguity and improves diagnostic accuracy. Significance: Unequivocal identification of the protein causing amyloidosis disease is crucial for correct diagnosis and treatment. As a proof of principle, we selected a number of cardiac and fat tissue biopsies from patients with various types of amyloidosis and show that a classical procedure of decellularisation enhances the specificity of the identification of the culprit protein reducing ambiguity and the risk of misdiagnosis. (C) 2017 The Authors. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available